DS Healthcare Receives Third Notice of Failure to Satisfy Continued Listing Rule

POMPANO BEACH, FL, August 22, 2016 (Newswire.com) - ​DS Healthcare Group, Inc. (DSKX) (the "Company") received a letter from Nasdaq dated August 19th, 2016 indicating that Nasdaq had not received the Company's Form 10-Q for the quarter ended June 30th, 2016, in addition to remaining delinquent in filing its Form 10-K for the period ended December 31, 2015 (the "Initial Delinquent Filing"). As a result, Nasdaq indicated that the Company does not comply with the Nasdaq Listing Rules (the "Rules") for continued listing.

The Company's plan of compliance with respect to its Initial Delinquent Filing was submitted to Nasdaq on May 11, 2016. Nasdaq made an additional information request dated May 27, 2016 ("May 27 Letter"), wherein Nasdaq staff requested, among other items, that the Company provide a detailed description of the steps required to be completed before the Company can become current in its periodic reporting obligations. Any exception to allow the Company to regain compliance, if granted, will be limited to a maximum of 180 calendar days from the due date of the Initial Delinquent Filing, or October 11, 2016.

About DS Healthcare Group

DS Healthcare Group Inc. develops novel biotechnology for topical therapies. It markets through online channels, specialty retailers, distributors, pharmacies, and physicians. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Healthcare Group or its flagship brands, visit www.dshealthgroup.com.

Forward-looking statements

Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing, current litigation against the Company, ongoing regulatory investigations of the Company, Nasdaq's trading halt of the Company's common stock and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at www.sec.gov.

Investor Relations

DS Healthcare Group

(888) 404-7770 ext. 3

[email protected]

Source: DS Healthcare Group